Consumer Retailing Healthcare Sector

Atomo Diagnostics

Market Cap: AU$12.4m

Engages in the development and sale of medical devices worldwide.

Frequency Exchange

Market Cap: CA$11.0m

Focuses on the development and commercialization of a wearable frequency delivery system that provides programs for health, wellness, and performance enhancement.

Innovotech

Market Cap: CA$10.9m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Biomerica

Market Cap: US$7.9m

A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.

Apollomics

Market Cap: US$7.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Co-Diagnostics

Market Cap: US$7.8m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

StimCell Energetics

Market Cap: US$7.8m

A biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States.

Carisma Therapeutics

Market Cap: US$7.7m

A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.

Turnstone Biologics

Market Cap: US$7.7m

Operates as a biotechnology company.

Inspire Veterinary Partners

Market Cap: US$7.6m

Owns and operates veterinary hospitals in the United States.

Evoke Pharma

Market Cap: US$7.6m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

BioVaxys Technology

Market Cap: CA$10.3m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

Crescita Therapeutics

Market Cap: CA$10.3m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Ainos

Market Cap: US$7.5m

A healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine.

Tissue Repair

Market Cap: AU$11.5m

A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.

Sensei Biotherapeutics

Market Cap: US$7.4m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

Lipella Pharmaceuticals

Market Cap: US$7.4m

A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.

GT Biopharma

Market Cap: US$7.3m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

Yubo International Biotech

Market Cap: US$7.3m

Through its subsidiaries, focuses on the research and development and application of endometrial stem cells in Hong Kong and the People’s Republic of China.

Traws Pharma

Market Cap: US$7.3m

A clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.

Telo Genomics

Market Cap: CA$10.0m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

China Pharma Holdings

Market Cap: US$7.2m

Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.

Citius Pharmaceuticals

Market Cap: US$7.2m

A biopharmaceutical company, focuses on the development and commercialization of critical care products.

PharmaCyte Biotech

Market Cap: US$7.2m

A biotechnology company, develops and commercializes cellular therapies for cancer in the United States.

Mainz Biomed

Market Cap: US$7.2m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

Medicure

Market Cap: CA$9.8m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Healixa

Market Cap: US$7.1m

Operates as a technology company with assets in both healthtech and fintech.

Cytophage Technologies

Market Cap: CA$9.7m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

Percheron Therapeutics

Market Cap: AU$10.9m

Engages in the research and development of novel antisense pharmaceuticals in Australia.

Theracryf

Market Cap: UK£5.2m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.

Innovative Eyewear

Market Cap: US$7.0m

Engages in the development and sale of smart eyeglasses and sunglasses in North America.

Kelyniam Global

Market Cap: US$7.0m

A medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States.

Univec

Market Cap: US$6.9m

Provides health care services in the United States.

Cardio Diagnostics Holdings

Market Cap: US$6.9m

Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

PharmaCielo

Market Cap: CA$9.4m

Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.

MetaVia

Market Cap: US$6.8m

A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.